Ristocetin

von Willebrand factor ; Homo sapiens







438 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 19497443 Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). 2009 Jun 9 4
102 19506359 Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. 2009 1
103 19506360 Autosomal dominant von Willebrand disease type 2M. 2009 3
104 19647361 Kinetic study of von Willebrand factor self-aggregation induced by ristocetin. 2009 Oct 3
105 19694940 Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. 2009 Nov 9
106 19875727 Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. 2009 Dec 4 2
107 17786534 Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma. 2008 Oct 2
108 17977030 Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. 2008 May-Jun 11
109 18282712 Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. 2008 Apr 1
110 18312368 Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease. 2008 May 1
111 18327408 Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. 2008 Mar 1
112 18445014 Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI. 2008 Jul 1
113 18485089 NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. 2008 Aug 1
114 18521510 Role of membrane cholesterol in platelet calcium signalling in response to VWF and collagen under stasis and flow. 2008 Jun 1
115 18600088 Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population. 2008 Jul 1
116 18637125 N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets. 2008 Nov 3
117 18786009 Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience. 2008 Nov 1
118 18786010 Prophylaxis in von Willebrand disease. 2008 Nov 1
119 18845909 A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets. 2008 Oct 1
120 19110525 [Urgent hemostatic control with Confact F for ovarian bleeding complicated by an unknown type of von Willebrand disease]. 2008 Dec 1
121 17137472 Risk of excessive bleeding associated with marginally low von Willebrand factor and mild platelet dysfunction. 2007 Feb 1
122 17200766 Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery. 2007 Jan 1
123 17389010 Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. 2007 Jul 1
124 17403090 Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients. 2007 Jun 1
125 17439628 von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery. 2007 Jul 2
126 17549293 Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study. 2007 Jun 1
127 17578514 Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. 2007 Jul 2
128 17598011 The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha. 2007 Jul 1
129 17701477 Management of inherited von Willebrand disease in 2007. 2007 2
130 18055988 Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. 2007 Dec 3
131 18064311 A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. 2007 Dec 3
132 16420575 The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. 2006 Feb 1
133 16430944 Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13. 2006 1
134 16607078 Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. 2006 Jan 2
135 16704443 Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease. 2006 Jun 5
136 16706984 von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively. 2006 Jun 4
137 16862517 A short history of diagnostic tests for von Willebrand disease: in memory of Barry Firkin (1930 to 2001) and Ted Zimmerman (1937 to 1988). 2006 Jul 1
138 16862522 Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. 2006 Jul 2
139 16977566 Diagnosis of inherited von Willebrand disease: a clinical perspective. 2006 Sep 1
140 16977573 Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. 2006 Sep 1
141 17047284 Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor. 2006 1
142 15459008 Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions. 2005 Feb 1 2
143 15630508 Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA. 2005 Jan 2
144 15705799 Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. 2005 Jun 1 2
145 15809291 Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13. 2005 Jun 17 1
146 15849522 Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys. 2005 Apr 1
147 15886805 Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor. 2005 May 4
148 15941906 A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications. 2005 Sep 15 1
149 15946221 Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. 2005 Jun 1
150 16014562 A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. 2005 Nov 1 1